Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7608-7615

  Dörk, Thilo ^a   Bendix, Regina ^a   Bremer, Michael ^a,a   Rades, Dirk ^a   Klöpper, Karin ^a   Skawran, Britta ^a   Hector, Ariadne ^a   Yamini, Paria ^a   Steinmann, Diana ^a   Weise, Sabine ^b   Stuhrmann, Manfred ^a   Karstens, Johann H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Department of Senology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ATM PROTEIN; GENE PRODUCT; GUANINE; THYMINE;

ADULT; AGED; ALLELISM; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; PROTEIN-SERINE-THREONINE KINASES; RNA SPLICE SITES; TUMOR SUPPRESSOR PROTEINS;

EID: 0035887491     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Genetic and hormonal risk factors in breast cancer
2. Current perspectives on radiation-induced breast cancer
3. Breast cancer genetics: What we know and what we need
4. Ataxia telangiectasia: A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection
5. The genetic defect in ataxia telangiectasia
6. The many substrates and functions of ATM
7. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
8. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species
9. Ataxia telangiectasia locus: Sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene
10. Role for ATM in DNA damage-induced phosphorylation of BRCA1
11. Ataxia-telangiectasia. A review of 101 cases
12. Cancer in ataxia-telangiectasia patients
13. Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer
14. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia and lymphoma, and breast cancer
15. Mortality of carriers of ataxia-telangiectasia mutations in ataxia-telangiectasia families
16. Malignant neoplasms in the families of patients with ataxia-telangiectasia
17. Breast and other cancers in families with ataxia-telangiectasia
18. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain
19. Incidence of cancer in 161 families affected by ataxia-telangiectasia
20. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer
21. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
22. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: Haplotype study in French AT families
23. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries
24. ATM mutations in cancer families
25. Breast cancer and radiotherapy in ataxia-telangiectasia heterozygote
26. Heterozygous ATM mutations do not contribute to early onset of breast cancer
27. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy
28. Heterozygosity for mutations of the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients
29. Absence of ATM truncations in patients with severe acute radiation reactions
30. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients
31. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer
32. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility
33. Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor
34. Common toxicity criteria: Version 2.0, an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy
35. ATM germline mutations in classical ataxia-telangiectasia patients in the Dutch population
36. Late effects of normal tissues consensus conference; LENT SOMA scale for all anatomic sites
37. Ataxia-telangiectasia: Structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression
38. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
39. A routine method for the establishment of permanent growing lymphoblastoid cell lines
40. Characterization of ATM gene mutations in 66 ataxia telangiectasia families
41. Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction
42. The product of the ATM gene is a 370 kDa nuclear phosphoprotein
43. Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia
44. Predominance of null mutations in ataxia-telangiectasia
45. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia
46. Splicing defects in the ataxia-telangiectasia gene, ATM: Underlying mutations and phenotypic consequences
47. Chromosomal and clinical radiosensitivity in breast cancer patients with different ATM gene mutations
48. Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation in comparison to ataxia telangiectasia heterozygote cells
49. Identification and chromosomal localisation of Atm, the mouse homolog of the ataxia-telangiectasia gene
50. Clustering of missense mutations in the ataxia telangiectasia gene in a sporadic T-cell leukaemia
51. FAT: A novel domain in PIK related kinases
52. An allelic variant at the ATM locus is implicated in breast cancer susceptibility
53. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer
54. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history
55. Exon-scanning mutation analysis of the ATM gene in patients with ataxia-telangiectasia
56. Temperature-sensitive, RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families
57. Are there low-penetrance p53 alleles? Evidence from childhood adrenocortical tumors
58. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability
59. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q
60. Association of HPC2/ELAC2 genotypes and prostate cancer
61. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations
62. Inactivation of ataxia-telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
63. Missense mutations at ATM gene and cancer risk
64. Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes
65. Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects
66. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia telangiectasia (AT) and AT heterozygotes
67. A suggested nomenclature for designating mutations